Questex Acquires ExL Events

Questex, a leading global business information and events company announced it has acquired ExL Events, Inc., expanding Questex’s presence in the global pharmaceutical, life science and healthcare markets.

ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life science and healthcare communities. Kerry Gumas, Questex President and Chief Executive Officer, said ExL will complement the services currently provided to those markets by Questex’s Fierce Life Science & Healthcare group of digital media titles and events.

The founders of ExL Events, Bryon Main, President and Chief Executive Officer, and Ethan Denkensohn, Chief Financial and Operating Officer, will continue to lead the organization and retain their existing staff. ExL Events, which will continue to operate from its New York headquarters, produces more than 70 annual events in the United States, Europe and Asia for pharmaceutical, biotechnology, medical device, diagnostics and contract research organizations; hospitals and physicians; and others.

“For the last 12 years, ExL Events has served the informational and networking needs of the dynamic and rapidly evolving global healthcare and pharmaceutical sectors through high-quality conferences that deliver important topical information and interactive networking opportunities,” said Main. “Having Questex’s many resources at our fingertips will fuel investment and global expansion opportunities for ExL Events. We look forward to working together to drive growth and innovation for the business and our customers.”

“With access to the media and information resources of the company, notably the Fierce LifeSciences & Healthcare group, we will have the opportunity to add value to our client solutions offering a strong combination of face-to-face events and year-round marketing, lead-generation, online learning and other information products to our clients and audiences. Going forward, we will remain completely focused on meeting the needs of our clients, and we will continue to innovate, bringing new events and services to market in each of our main business areas,” said Denkensohn of ExL Events.

“We are pleased to welcome Bryon, Ethan and the entire ExL Events team to the company,” said Gumas. “They have done an excellent job in building ExL Events into a high-service, high-value producer of events, which we believe will be well complemented by our industry-leading portfolio of digital media titles serving the industry.”

About Questex
Questex is a leading global business information and events company serving corporate and government clients and industries that are driving economic growth and business innovation around the world.

The company drives business investment, innovation and demand-creation in the markets it serves by bringing together investors, buyers, sellers and professionals through its over 100 trade shows, conferences and other business events, informing them through more than 100 business media and information products and supporting clients with a comprehensive platform of marketing solutions. Questex’s industry-focused business units include Life Sciences & Healthcare, Hospitality & Travel, Beauty & Wellness, and Technology & Telecom groups.

Questex is headquartered in Newton, Massachusetts. The company employs more than 350 dedicated professional staff members, who are located in offices throughout the United States, Europe and the Asia-Pacific region

 

 

Company: ExL Events


ExL Events develops engaging, content-driven conferences and partnered events for dynamic industry audiences, including pharmaceutical, biotechnology, medical device, diagnostic and contract research organizations; hospital networks; physicians; and communications and other entities. Behind our diverse event portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events that facilitate the exchange of critical information between industry professionals and suppliers who support shared goals.

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.